|
Market Closed -
Other stock markets
|
Pre-market 09:03:46 am | |||
| 209.03 USD | +4.96% |
|
209.16 | +0.06% |
| 08:03am | Biogen Gets FDA Approval for Leqembi Iqlik as Initiation Dose for Early Alzheimer's Disease | MT |
| 14/07 | Eisai, Biogen Get FDA Approval for Treatment for Early Alzheimer's Disease | DJ |
| Market Cap | 29.4B 25.83B 23.95B 22.03B 41.61B 2,811B 42.5B 286B 112B 1,381B 110B 108B 4,776B | P/E 2026 * |
33.9x | P/E 2027 * | 17.4x |
|---|---|---|---|---|---|
| Enterprise Value | 34.91B 30.67B 28.44B 26.15B 49.41B 3,338B 50.47B 339B 133B 1,640B 131B 128B 5,670B | EV / Sales 2026 * |
3.47x | EV / Sales 2027 * | 3.15x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | +0.06% | ||
| 1 week | -3.28% | ||
| Current month | -3.25% | ||
| 1 month | +4.49% | ||
| 3 months | +20.85% | ||
| 6 months | +12.61% | ||
| Current year | +18.77% |
| 1 week | 194.37 |  | 212 |
| 1 month | 193.2 | | 219.72 |
| Current year | 160.36 | | 219.72 |
| 1 year | 121.05 | | 219.72 |
| 3 years | 110.04 | | 281.12 |
| 5 years | 110.04 | | 358.77 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.96% | -3.28% | +55.75% | -24.71% | 29.4B | |
| -0.22% | +1.35% | +16.79% | -7.70% | 67.61B | |
| -0.63% | -9.21% | +37.82% | +200.20% | 51.6B | |
| +0.36% | +40.00% | +40.00% | +40.00% | 43B | |
| -1.26% | -0.39% | -49.63% | -53.84% | 40.94B | |
| -1.85% | -15.99% | +99.20% | -46.78% | 27.09B | |
| -2.12% | -2.25% | +66.54% | +82.33% | 23.32B | |
| -0.67% | +1.48% | +10.61% | +188.35% | 19.92B | |
| -2.12% | -3.72% | +61.37% | +126.08% | 16.91B | |
| -3.27% | +7.63% | +78.78% | +360.28% | 16.84B | |
| Average | -1.17% | -1.83% | +41.72% | +86.42% | 33.66B | |
| Weighted average by Cap. | -0.85% | -2.34% | +33.36% | +62.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.06B 8.84B 8.19B 7.54B 14.24B 962B 14.54B 97.7B 38.21B 473B 37.77B 36.94B 1,634B | 10.4B 9.14B 8.47B 7.79B 14.72B 994B 15.03B 101B 39.5B 488B 39.04B 38.19B 1,689B |
| Net income | 1.42B 1.24B 1.15B 1.06B 2B 135B 2.05B 13.75B 5.38B 66.51B 5.32B 5.2B 230B | 1.98B 1.74B 1.61B 1.48B 2.8B 189B 2.86B 19.21B 7.51B 92.89B 7.42B 7.26B 321B |
| Net Debt | 5.51B 4.84B 4.49B 4.13B 7.8B 527B 7.96B 53.51B 20.93B 259B 20.68B 20.23B 895B | 3.38B 2.97B 2.76B 2.54B 4.79B 324B 4.89B 32.88B 12.86B 159B 12.71B 12.43B 550B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | USD 209.03 | +4.96% | 2,254,146 |
| 10/07/26 | USD 199.15 | +0.12% | 1,133,120 |
| 09/07/26 | USD 198.91 | -0.72% | 1,657,327 |
| 08/07/26 | USD 200.36 | -2.60% | 1,947,888 |
| 07/07/26 | USD 205.70 | -1.32% | 1,156,880 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
